Deffebach Mark E, Humphrey Linda
Division of Hospital and Specialty Medicine, Pulmonary and Critical Care Medicine, Portland VA Health Care System, P3PULM, 3710 Southwest US Veterans Hospital Road, Portland, OR 97201, USA; Department of Medicine, Oregon Health and Science University, Portland, OR 97239, USA.
Department of Medicine, Oregon Health and Science University, Portland, OR 97239, USA; Division of Hospital and Specialty Medicine, Portland VA Health Care System, P3PULM, 3710 Southwest US Veterans Hospital Road, Portland, OR 97201, USA.
Surg Clin North Am. 2015 Oct;95(5):967-78. doi: 10.1016/j.suc.2015.05.006.
Screening for lung cancer in high-risk individuals with annual low-dose computed tomography has been shown to reduce lung cancer mortality by 20% and is recommended by multiple health care organizations. Lung cancer screening is not a specific test; it is a process that involves appropriate selection of high-risk individuals, careful interpretation and follow-up of imaging, and annual testing. Screening should be performed in the context of a multidisciplinary program experienced in the diagnosis and management of lung nodules and early-stage lung cancer.
对高危个体进行年度低剂量计算机断层扫描筛查肺癌已被证明可将肺癌死亡率降低20%,并得到多个医疗保健组织的推荐。肺癌筛查不是一项特定的检查;它是一个过程,包括对高危个体进行适当选择、对影像进行仔细解读和随访以及年度检测。筛查应在一个在肺结节和早期肺癌的诊断和管理方面经验丰富的多学科项目背景下进行。